Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
29.9M
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
8.72M
-
Shares change
-
+47.5K
-
Total reported value, excl. options
-
$143M
-
Value change
-
-$152K
-
Put/Call ratio
-
0.91
-
Number of buys
-
20
-
Number of sells
-
-24
-
Price
-
$16.36
Significant Holders of Profound Medical Corp. - Common Shares (PROF) as of Q2 2021
62 filings reported holding PROF - Profound Medical Corp. - Common Shares as of Q2 2021.
Profound Medical Corp. - Common Shares (PROF) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.72M shares
of 29.9M outstanding shares and own 29.18% of the company stock.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.3M shares), FIL Ltd (875K shares), LETKO, BROSSEAU & ASSOCIATES INC (811K shares), GAGNON SECURITIES LLC (801K shares), Redmile Group, LLC (787K shares), PURA VIDA INVESTMENTS, LLC (644K shares), Blackcrane Capital, LLC (544K shares), ROYCE & ASSOCIATES LP (477K shares), AWM Investment Company, Inc. (349K shares), and Gagnon Advisors, LLC (277K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.